Selected article for: "assay time and false positive"
Author: Kucera, Katerina S.; Taylor, Jennifer L.; Robles, Veronica R.; Clinard, Kristin; Migliore, Brooke; Boyea, Beth Lincoln; Okoniewski, Katherine C.; Duparc, Martin; Rehder, Catherine W.; Shone, Scott M.; Fan, Zheng; Raspa, Melissa; Peay, Holly L.; Wheeler, Anne C.; Powell, Cynthia M.; Bailey, Donald B.; Gehtland, Lisa M.
Title: A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check
  • Cord-id: 8uq9dytj
  • Document date: 2021_3_21
    • ID: 8uq9dytj
    Snippet: Prior to statewide newborn screening (NBS) for spinal muscular atrophy (SMA) in North Carolina, U.S.A., we offered voluntary screening through the Early Check (EC) research study. Here, we describe the EC experience from October 2018 through December 2020. We enrolled a total of 12,065 newborns and identified one newborn with 0 copies of SMN1 and two copies of SMN2, consistent with severe early onset of SMA. We also detected one false positive result, likely stemming from an unrelated blood diso
    Document: Prior to statewide newborn screening (NBS) for spinal muscular atrophy (SMA) in North Carolina, U.S.A., we offered voluntary screening through the Early Check (EC) research study. Here, we describe the EC experience from October 2018 through December 2020. We enrolled a total of 12,065 newborns and identified one newborn with 0 copies of SMN1 and two copies of SMN2, consistent with severe early onset of SMA. We also detected one false positive result, likely stemming from an unrelated blood disorder associated with a low white blood cell count. We evaluated the timing of NBS for babies enrolled prenatally (n = 932) and postnatally (n = 11,133) and reasons for delays in screening and reporting. Although prenatal enrollment led to faster return of results (median = 13 days after birth), results for babies enrolled postnatally were still available within a timeframe (median = 21 days after birth) that allowed the opportunity to receive essential treatment early in life. We evaluated an SMA q-PCR screening method at two separate time points, confirming the robustness of the assay. The pilot project provided important information about SMA screening in anticipation of forthcoming statewide expansion as part of regular NBS.

    Search related documents:
    Co phrase search for related documents
    • absence presence and additional information: 1, 2, 3
    • absence presence and long short: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and long short term: 1, 2, 3, 4, 5
    • acceptability feasibility and additional information: 1
    • acceptability feasibility and long short: 1, 2, 3
    • acceptability feasibility and long short term: 1, 2, 3
    • accuracy assess and additional information: 1
    • accuracy assess and long short: 1, 2
    • accuracy assess and long short term: 1
    • additional information and long short: 1, 2
    • additional information and long short term: 1
    • loading dose and long short: 1
    • loading dose and long short term: 1